Weaning Plan for Short-Term High-Dose Prednisolone Therapy

Understanding HPA Axis Suppression with Short-Term Steroid Use

• HPA axis suppression varies significantly between individuals, but is generally anticipated in patients receiving more than 7.5 mg of prednisolone equivalent daily for more than 3 weeks 1, 2
• The EULAR guidelines on glucocorticoid therapy indicate that adrenal suppression risk is difficult to predict but is primarily a concern with treatments lasting more than 3 weeks 1, 2

Clinical Approach to Short-Term Prednisolone Use

• For patients who have received high-dose prednisolone for only 5 days, monitoring for symptoms of adrenal insufficiency (fatigue, weakness, dizziness, nausea) is reasonable but not mandatory 3
• No formal weaning schedule is required for patients who have received high-dose prednisolone for only 5 days 2

Special Considerations and Exceptions

• Patients with pre-existing HPA axis dysfunction may require more cautious approach 1
• Patients who have received multiple recent courses of steroids may have cumulative suppression and might benefit from a brief taper 2
• If the patient is experiencing severe stress (major surgery, critical illness) within 1-2 weeks after steroid discontinuation, consider stress-dose steroids as a precaution 3

Common Pitfalls to Avoid

• Unnecessarily prolonging steroid exposure through overly cautious tapering when not indicated 1
• Confusing recommendations for immune checkpoint inhibitor-related adverse events (which often require longer tapering) with standard short-term steroid courses 4, 5
• Over-testing for adrenal insufficiency in asymptomatic patients after short courses 3